BackBiocept Overview

Biocept Total Current Liabilities

Biocept's total current liabilities is $4.9M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$4.90M
49.01% YoYΔ $-4.71M vs prior year quarter

Peer average

Loading

Biocept Total Current Liabilities History

Loading

Biocept vs. peers: Total Current Liabilities Comparison

Loading

Biocept Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biocept (BIOC) FAQ

As of the most recent data (June 2023), BIOC shows a total current liabilities of $4.9M. That compares with $9.6M in the prior-year period — down 49.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOC's total current liabilities is now $4.9M (was $9.6M) — a 49.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biocept is outperforming or lagging.

Tracking BIOC's total current liabilities over time shows whether Biocept is scaling, shrinking, or reshaping that part of the business. The current reading is $4.9M That compares with $9.6M in the prior-year period — down 49.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Biocept's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $4.9M) with ownership activity and broader fundamentals.

Biocept's total current liabilities is $4.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.